undefined
When telecommunications companies began deploying fifth-generation wireless networks in 2019, they promised transformative connectivity: autonomous vehicles, remote surgery, smart cities operating in real-time. Global investment in 5G infrastructure reached $19.1 billion by 2024. Verizon alone committed $18.2 billion to build out its network. AT&T invested $140 billion in wireless infrastructure over five years. The technology marched forward with remarkable speed.
What moved more slowly was the science assessing potential health effects. The radiofrequency exposure limits governing 5G deployment—the safety thresholds determining how much electromagnetic radiation humans can absorb from wireless devices and infrastructure—were established by the Federal Communications Commission in 1996, during the era of early flip phones. Those limits remain unchanged today, despite the deployment of networks operating at frequencies up to 86 GHz, substantially higher than any previous consumer wireless technology.
This investigation examines the architecture of 5G health science: the research indicating potential harm, the studies finding no effects, the regulatory frameworks governing deployment, and the financial forces shaping what questions get asked and answered. The evidence reveals not a simple narrative of danger or safety, but a complex landscape where legitimate scientific uncertainty intersects with substantial industry influence over both research funding and regulatory processes.
The most comprehensive assessment of radiofrequency radiation health effects to date came from an unexpected source: the U.S. government's own National Toxicology Program. Between 2009 and 2018, NTP researchers conducted a $30 million study exposing thousands of rats and mice to 2G and 3G radiofrequency radiation for their entire lives—approximately two years.
The findings, published in 2018, were unambiguous on one count: they found "clear evidence" of malignant schwannomas (tumors) in the hearts of male rats exposed to RF radiation. They also found "some evidence" of malignant gliomas (brain tumors) in male rats, and tumors in the adrenal glands. DNA damage appeared in multiple exposed groups. Birth weights decreased.
What made these findings particularly significant was that the tumors appeared at exposure levels below current FCC limits. The study used whole-body exposure of 1.5 to 6 watts per kilogram—comparable to what humans experience, though higher than typical phone use. The current FCC limit is 1.6 W/kg for partial body exposure.
"Our findings of cancerous tumors in glial cells of the heart and brain are consistent with and reinforce the results of the US National Toxicology Program studies."
Dr. Fiorella Belpoggi, Ramazzini Institute — Environmental Research, 2018The NTP findings were corroborated by independent research from Italy's Ramazzini Institute. In a 2018 study that exposed 2,448 rats to environmental levels of RF radiation—the kind of exposure from cell towers rather than phones—researchers found the same type of heart tumors the NTP had identified. The Ramazzini study was notable because tumors appeared at exposure levels 1,000 times lower than those used in the NTP research, at intensities of 50 volts per meter, well within what people experience near cell towers.
These studies examined 2G and 3G frequencies. Research specifically on 5G frequencies, particularly the millimeter wave bands between 28-86 GHz, remains limited. The NTP has acknowledged this gap. So has the FDA, which last conducted independent laboratory research on RF radiation in the 1990s.
In 2019, the FCC voted 3-2 to maintain its 1996 exposure standards without revision, despite petitions from health advocates presenting the NTP findings and other research. The commission concluded that the existing limits adequately protect public health. FCC Commissioner Jessica Rosenworcel, dissenting, noted: "It is striking that we are finally revisiting our radio frequency emissions policies, and not a single document in the record of this proceeding reflects the view of any health or safety expert at a federal health or safety agency."
Environmental Health Trust, Children's Health Defense, and other organizations sued the FCC, challenging the decision. In August 2021, the U.S. Court of Appeals for the D.C. Circuit ruled in their favor, finding that the FCC had "failed to provide a reasoned explanation" for its determination that the guidelines adequately protect against harmful effects. The court specifically cited the agency's failure to address evidence regarding long-term exposure, effects on children, environmental impacts, and non-thermal biological effects.
The decision did not declare the FCC's limits unsafe. It found the agency had not adequately responded to evidence and arguments suggesting they might be. As of 2024, the FCC has initiated a review process but has not updated the 1996 standards.
The Food and Drug Administration maintains a different position. In a February 2020 statement reaffirmed in 2024, the FDA stated: "Based on our ongoing evaluation, we have not found sufficient evidence that there are adverse health effects in humans caused by exposures at or under the current limits." However, FDA scientists acknowledged to Congress that the agency had reviewed existing studies but had not conducted new independent laboratory research since the 1990s, relying instead on literature review.
In May 2011, the World Health Organization's International Agency for Research on Cancer convened 31 scientists from 14 countries to assess the carcinogenic potential of radiofrequency electromagnetic fields. After reviewing all available evidence—human epidemiological studies, animal research, and mechanistic data—they classified RF radiation as Group 2B: "possibly carcinogenic to humans."
Group 2B is the same classification applied to lead, chloroform, and gasoline exhaust. It means limited evidence of carcinogenicity in humans and less than sufficient evidence in experimental animals. The classification was based primarily on epidemiological studies finding increased glioma risk associated with wireless phone use, particularly research by Swedish oncologist Dr. Lennart Hardell.
Hardell's case-control studies, conducted at Örebro University Hospital in Sweden, consistently found elevated brain tumor risk associated with long-term mobile phone use, particularly when the phone was used on the same side of the head where the tumor developed. A 2013 meta-analysis he co-authored, reviewing 16 case-control studies, found that 1,000 or more hours of mobile phone use was associated with a statistically significant increased risk of brain tumors.
Hardell's research has been controversial. Industry-funded researchers have criticized his methodology, particularly his reliance on subjects' recall of phone use patterns years earlier. Hardell disclosed no industry funding and has been an outspoken critic of industry influence in research. He has served as an expert witness in litigation against telecommunications companies, which industry representatives cite as evidence of bias. Hardell maintains his research independence.
Between 2018 and 2023, as 5G networks deployed across the United States, the telecommunications industry spent $240 million on federal lobbying. CTIA—The Wireless Association, representing carriers including Verizon, AT&T, and T-Mobile, spent $98.4 million during this period. Verizon spent $79.3 million. AT&T spent $31.7 million.
These expenditures focused on spectrum allocation, infrastructure deployment regulations, and maintaining current RF exposure standards. CTIA President Meredith Attwell Baker, who served as an FCC Commissioner from 2009 to 2011 before joining the industry group in 2014, exemplifies the revolving door between regulators and the regulated.
The industry also influences research. CTIA's Wireless Research Program has distributed approximately $12 million for RF health research since 1999. While this might seem substantial, it represents less than 0.01% of industry annual revenues of approximately $200 billion. For comparison, the pharmaceutical industry typically spends 15-20% of revenue on research and development.
Industry funding doesn't necessarily bias research, but it shapes which questions get asked. A 2007 systematic review published in Environmental Health Perspectives found that studies funded exclusively by industry were substantially less likely to report statistically significant effects of RF exposure than independently funded studies. Of studies funded exclusively by industry, 27% found effects; of studies with no industry funding, 67% found effects.
The FCC's exposure limits are based largely on standards developed by the Institute of Electrical and Electronics Engineers (IEEE), the world's largest technical professional organization. IEEE's International Committee on Electromagnetic Safety sets RF exposure guidelines based on preventing tissue heating—the thermal effects of electromagnetic radiation absorption.
The current IEEE standard, updated in 2019, recommends limiting whole-body exposure to 0.4 W/kg and localized exposure to 10 W/kg. These thresholds are designed to prevent the body from absorbing enough energy to raise tissue temperature to harmful levels. The standards assume that if heating is prevented, harm is prevented.
However, a 2021 investigation found that of the 30 members on the IEEE standards committee, 24 had documented ties to the telecommunications industry through employment, consulting, or research funding. Several committee members issued minority opinions when the 2019 standard was adopted, arguing it inadequately addressed non-thermal biological effects—cellular and molecular changes that occur without measurable tissue heating.
"The existing FCC and ICNIRP limits are not protective of public health."
Dr. David Carpenter, Director, Institute for Health and Environment, University at Albany — BioInitiative Report, 2012The BioInitiative Working Group, consisting of 29 independent scientists and health experts, reviewed over 3,800 studies and concluded in 2012 that existing safety standards are inadequate. They recommend exposure limits 1,000 times lower than current FCC standards, arguing that biological effects occur far below levels that cause heating. The report has been controversial, criticized by industry groups and some regulatory agencies for its methodology. However, the European Environment Agency cited it in calling for precautionary measures.
International standards come from the International Commission on Non-Ionizing Radiation Protection (ICNIRP), a non-governmental organization whose guidelines are adopted by many countries worldwide. In March 2020, ICNIRP released updated RF guidelines maintaining that protection against heating effects is sufficient, with limits of 0.08 W/kg for whole-body exposure.
Over 240 scientists from 42 countries signed appeals calling ICNIRP's guidelines inadequate. A 2020 investigation found that 13 of ICNIRP's 14 commission members had published articles dismissing wireless health risks, raising questions about the organization's objectivity in evaluating contested evidence. ICNIRP maintains it is independent and receives no industry funding, operating on approximately €100,000 annually from membership fees and scientific organizations.
Fifth-generation networks operate differently from their predecessors. While 4G LTE used frequencies primarily below 6 GHz, 5G employs a wider spectrum: low-band frequencies from 600 MHz to 1 GHz, mid-band from 2.5 to 6 GHz, and high-band millimeter waves from 24 to 86 GHz. The higher frequencies enable faster data transmission but penetrate material—including human tissue—less deeply.
This creates a paradox for health assessment. Higher frequencies penetrate less, potentially affecting primarily skin and eye tissues rather than deeper organs. However, 5G networks require substantially more infrastructure—small cell antennas deployed every few hundred feet in dense areas, rather than the larger, more distant towers of previous generations. This increases the number of exposure sources, though each individual source may emit less power.
Research on millimeter wave health effects remains limited. The frequencies haven't been widely used for consumer applications before 5G. Most existing RF health research examined the lower frequencies used by 2G, 3G, and 4G networks, or by Wi-Fi and microwave ovens (typically around 2.4 GHz).
The NTP has acknowledged this gap. In testimony to Congress, NTP scientists stated that while their research on 2G and 3G frequencies found "clear evidence" of tumors, they cannot extrapolate those findings to 5G millimeter wave frequencies without additional research. That research has not been funded at scale.
Twenty-eight countries have adopted precautionary policies limiting 5G or wireless infrastructure deployment near schools, despite regulatory agencies maintaining that current exposure limits are protective. France banned Wi-Fi in nursery schools in 2015 and requires it to be turned off in elementary schools when not in use. Belgium's Brussels region halted 5G deployment in 2019 pending health assessment, though it resumed in 2022. Switzerland implemented stricter exposure limits than ICNIRP recommendations, though they still permit 5G deployment.
These policies reflect application of the precautionary principle: when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if cause-and-effect relationships are not fully established scientifically. The principle is enshrined in the 1992 Rio Declaration and European Union law.
The United States has not adopted the precautionary principle in RF regulation. The FCC's approach requires demonstration of harm before implementing restrictions, rather than requiring demonstration of safety before approving deployment. This reflects a fundamental difference in regulatory philosophy.
The World Health Organization's position on RF radiation contains an apparent contradiction. In 2011, WHO's cancer agency IARC classified RF radiation as possibly carcinogenic. Yet WHO's main EMF Project, which assesses electromagnetic field health effects, maintains that "to date, no adverse health effects have been established as being caused by mobile phone use."
Dr. Emilie van Deventer, head of WHO's EMF Project, explained that WHO "takes the precautionary approach" and that a comprehensive health risk assessment of RF fields is planned for completion in 2026-2027. This assessment will specifically address 5G frequencies and inform updated guidance.
However, a 2017 investigation found that several scientists serving on WHO EMF Project advisory panels had undisclosed industry funding or affiliations. WHO subsequently strengthened its conflict-of-interest disclosure requirements, but questions about the composition of expert panels persist.
"We are currently performing a large-scale experiment on the population."
Dr. Lennart Hardell, Örebro University Hospital — Oncology Letters, 2019What the existing evidence establishes with certainty is limited but significant: high-level RF exposure causes tissue heating. At sufficiently high levels, this heating can damage tissue, particularly eyes and testes. Current regulatory limits are designed to prevent such heating, and compliance with those limits does prevent thermal injury.
What remains contested is whether RF exposure below heating thresholds causes biological effects that could lead to health harm over long-term exposure. The NTP and Ramazzini studies found tumors in animals at exposure levels that did not cause measurable heating. Epidemiological studies, particularly Hardell's research, found associations between long-term phone use and brain tumors. But other large epidemiological studies, including parts of the INTERPHONE study, found no such associations.
The mechanism by which non-thermal RF exposure might cause biological effects remains unclear. Proposed mechanisms include oxidative stress, DNA damage, effects on calcium channels in cell membranes, and disruption of circadian rhythms through effects on melatonin. Laboratory research has found evidence for each of these mechanisms, but the findings are not consistent across studies.
What is not contested is that research specifically on 5G frequencies remains inadequate. The technology deployed globally based on safety standards established for different frequencies and exposure patterns. Whether that represents acceptable risk management or a failure of precaution depends substantially on one's assessment of the existing evidence and one's tolerance for uncertainty.
The telecommunications industry generated approximately $1.8 trillion in global revenue in 2023. In the United States alone, the industry's annual revenues approach $200 billion. Against this scale, the $240 million spent on lobbying represents roughly 0.01% of revenue—a modest investment to shape regulatory outcomes affecting hundreds of billions in infrastructure deployment.
Spectrum auctions create a particular dynamic. Between 2015 and 2021, the FCC collected $81.9 billion selling wireless frequencies to carriers. This revenue flows to the U.S. Treasury, but it creates an incentive structure where the agency tasked with regulating wireless safety also benefits financially from wireless expansion. The FCC maintains that spectrum licensing and health regulation are separate functions performed by different bureaus, but critics note the institutional incentive nonetheless.
Research funding reflects similar imbalances. While industry has spent approximately $12 million on independent RF health research over 25 years through CTIA programs, it has spent $240 million on lobbying in just six years. The National Toxicology Program's comprehensive study cost $30 million—substantially more than industry's cumulative independent research funding, but that study was completed in 2018 and no comparable follow-up research on 5G frequencies has been funded at federal level.
The FDA's radiofrequency safety program operates on approximately $2-3 million annually. The agency last conducted independent laboratory research on RF radiation in the 1990s. It has reviewed existing literature but has not generated new data as technology advanced through multiple generations from 2G to 5G.
As of 2024, 5G networks cover approximately 40% of the global population. Infrastructure deployment continues. Research on health effects lags behind deployment by years or decades—the nature of long-term exposure studies. The WHO's comprehensive health risk assessment is scheduled for 2026-2027. The FCC's review of its exposure limits, ordered by the court, proceeds without a definitive timeline.
What this investigation documents is not definitive evidence of harm, nor definitive evidence of safety. It documents a regulatory and research architecture where substantial financial interests intersect with scientific uncertainty, where safety standards remain unchanged for three decades despite technological transformation, where the most comprehensive government research found evidence of cancer in animals but regulatory agencies maintain that current limits protect human health.
The question is not whether 5G will be deployed—it already has been, globally, at a scale of hundreds of billions of dollars. The question is whether the science assessing its effects will catch up, whether regulatory standards will be updated based on that science, and whether the institutional structures shaping both research and regulation adequately account for the financial interests involved.
Swedish oncologist Lennart Hardell characterized 5G deployment as "a large-scale experiment on the population." Whether that characterization is alarmist or accurate depends substantially on how one weighs incomplete evidence, tolerates uncertainty, and assesses the independence of the institutions charged with protecting public health when substantial economic interests are at stake.